Download presentation
Presentation is loading. Please wait.
1
Volume 18, Issue 11, Pages 647-653 (November 2016)
Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor Nick Beije, Wendy Onstenk, Jaco Kraan, Anieta M. Sieuwerts, Paul Hamberg, Luc Y. Dirix, Anja Brouwer, Felix E. de Jongh, Agnes Jager, Caroline M. Seynaeve, Ngoc M. Van, John A. Foekens, John W.M. Martens, Stefan Sleijfer Neoplasia Volume 18, Issue 11, Pages (November 2016) DOI: /j.neo Copyright © 2016 The Authors Terms and Conditions
2
Figure 1 PFS and OS according to HER2-CTC status. (A and C) PFS and OS, respectively, for the endocrine therapy cohort. (B and D) PFS and OS, respectively, for chemotherapy cohort. Neoplasia , DOI: ( /j.neo ) Copyright © 2016 The Authors Terms and Conditions
3
Figure 2 PFS and OS according to ER-CTC status. (A and C) PFS and OS, respectively, for the endocrine therapy cohort. (B and D) PFS and OS, respectively, for chemotherapy cohort. Neoplasia , DOI: ( /j.neo ) Copyright © 2016 The Authors Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.